In March 2024, Arecor Therapeutics pl, in partnership with TRx Biosciences Limited, revealed a joint effort to research and develop a formulation for an oral product that acts as a glucagon-like peptide-1 (GLP-1) receptor agonist
Significant Weight Loss: In higher-dose groups (12 mg), participants experienced average weight loss approaching 28% of body weight in long-term studies
With diabetes impacting multiple generations of his family, he approached the diagnosis the same way he did the game by focusing on the fundamentals, committing to lifestyle changes, and relying on his team to help him reach his goals
At week 24, the geometric mean percentage change from baseline was 7.4% (95% confidence interval (CI) 8.7, 26.2)
adults, driven by increasing obesity rates and growing awareness of weight management options
When you lose weight, metabolic rate drops beyond what youd predict from the reduction in body mass alone